{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:49:30Z","timestamp":1793746170670,"version":"4.6.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jmii.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:55:33Z","timestamp":1600937733000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"title":["COVID-19 associated with pulmonary aspergillosis: A literature review"],"prefix":"10.1016","volume":"54","author":[{"given":"Chih-Cheng","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng-Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2020.09.004_bib2","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2020.09.004_bib3","doi-asserted-by":"crossref","first-page":"105946","DOI":"10.1016\/j.ijantimicag.2020.105946","article-title":"Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2020.09.004_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","article-title":"Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents?","volume":"53","author":"Lai","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.09.004_bib5","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0961","article-title":"Co-infection and other clinical characteristics of COVID-19 in children","volume":"146","author":"Wu","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.jmii.2020.09.004_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2020.09.004_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.26125","article-title":"Influenza and COVID-19 co-infection: report of six cases and review of the literature","author":"Ozaras","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2020.09.004_bib8","first-page":"ciaa530","article-title":"Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2020.09.004_bib9","doi-asserted-by":"crossref","first-page":"198005","DOI":"10.1016\/j.virusres.2020.198005","article-title":"Co-infection with respiratory pathogens among COVID-2019 cases","volume":"285","author":"Zhu","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.jmii.2020.09.004_bib10","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.20-0498","article-title":"Primary respiratory bacterial coinfections in patients with COVID-19","author":"Chaudhary","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"20","key":"10.1016\/j.jmii.2020.09.004_bib11","first-page":"30121","article-title":"Co-infection with an atypical pathogen of COVID-19 in a young","volume":"S1684\u20131182","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.09.004_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2020.09.004_bib13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.amjmed.2020.02.025","article-title":"Pulmonary aspergillosis: what the generalist needs to know","volume":"133","author":"El-Baba","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2020.09.004_bib14","first-page":"430","article-title":"Diagnosing invasive pulmonary aspergillosis in ICU patients: putting the puzzle together","volume":"25","author":"Blot","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jmii.2020.09.004_bib15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0039-1696968","article-title":"Invasive pulmonary aspergillosis in nonimmunocompromised hosts","volume":"40","author":"Tudesq","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2020.09.004_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/crj.13036","article-title":"Aspergillosis related to severe influenza: a worldwide phenomenon?","volume":"13","author":"Liu","year":"2019","journal-title":"Clin Res J"},{"key":"10.1016\/j.jmii.2020.09.004_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jfma.2017.06.002","article-title":"Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections","volume":"116","author":"Ku","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2020.09.004_bib18","doi-asserted-by":"crossref","first-page":"O939","DOI":"10.1111\/1469-0691.12650","article-title":"Environmental variables associated with an increased risk of invasive aspergillosis","volume":"20","author":"Garcia-Vidal","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2020.09.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.3800247","article-title":"Pulmonary pathology of severe acute respiratory syndrome in Toronto","volume":"18","author":"Hwang","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmii.2020.09.004_bib20","doi-asserted-by":"crossref","first-page":"ofz247","DOI":"10.1093\/ofid\/ofz247","article-title":"Outcomes in Invasive pulmonary aspergillosis infections complicated by respiratory viral infections in patients with hematologic malignancies: a ccase-control study","volume":"6","author":"Magira","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2020.09.004_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007890-200101270-00021","article-title":"Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient","volume":"71","author":"Rossi","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jmii.2020.09.004_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.imlet.2007.01.005","article-title":"Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis","volume":"109","author":"Sainz","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jmii.2020.09.004_bib23","doi-asserted-by":"crossref","first-page":"e28680","DOI":"10.1371\/journal.pone.0028680","article-title":"Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2020.09.004_bib24","first-page":"344","article-title":"[Investigation of interleukin-10, tumor necrosis factor-alpha and interferon-gamma expression in experimental model of pulmonary aspergillosis]","volume":"45","author":"Ca\u011flar","year":"2011","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jmii.2020.09.004_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2249.2000.01382.x","article-title":"Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis","volume":"122","author":"Clemons","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jmii.2020.09.004_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1286-4579(99)00245-2","article-title":"Antifungal type 1 responses are upregulated in IL-10-deficient mice","volume":"1","author":"Del Sero","year":"1999","journal-title":"Microb Infect"},{"key":"10.1016\/j.jmii.2020.09.004_bib27","first-page":"1","article-title":"Understanding SARS-CoV-2-Mediated inflammatory responses: from mechanisms to potential therapeutic tools","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"key":"10.1016\/j.jmii.2020.09.004_bib28","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jmii.2020.09.004_bib29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2217\/fmb-2019-0043","article-title":"Kinetic host defense of the mice infected with Aspergillus Fumigatus","volume":"14","author":"Su","year":"2019","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jmii.2020.09.004_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2016.05.016","article-title":"Efficiency of interleukin 6 and interferon gamma in the differentiation of invasive pulmonary aspergillosis and pneumocystis pneumonia in pediatric oncology patients","volume":"48","author":"Shen","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2020.09.004_bib31","doi-asserted-by":"crossref","first-page":"e0123171","DOI":"10.1371\/journal.pone.0123171","article-title":"Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosis","volume":"10","author":"Camargo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2020.09.004_bib32","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s10067-020-05234-w","article-title":"A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab","volume":"39","author":"Cai","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jmii.2020.09.004_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-020-03046-7","article-title":"Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series","volume":"24","author":"Wang","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2020.09.004_bib34","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jmii.2020.09.004_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jmii.2020.09.004_bib36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2020.09.004_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2020.09.004_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30200-0","article-title":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series","volume":"20","author":"Lescure","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2020.09.004_bib39","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3201\/eid2607.201603","article-title":"Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient","volume":"26","author":"Blaize","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2020.09.004_bib40","doi-asserted-by":"crossref","first-page":"101752","DOI":"10.1016\/j.tmaid.2020.101752","article-title":"Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: a diagnostic challenge","author":"Antinori","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.jmii.2020.09.004_bib41","article-title":"Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - a case report","author":"Prattes","year":"2020","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.jmii.2020.09.004_bib42","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cmi.2020.05.032","article-title":"Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia","volume":"26","author":"Lahmer","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2020.09.004_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jof6020079","article-title":"Azole-resistant COVID-19-associated pulmonary aspergillosis in an immunocompetent host: a case report","volume":"6","author":"Meijer","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jmii.2020.09.004_bib44","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for Coronavirus Disease 19 (COVID-19)","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jmii.2020.09.004_bib45","article-title":"Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions","author":"Varshneya","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jmii.2020.09.004_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008662","article-title":"The Effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 Infection","volume":"13","author":"Saleh","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jmii.2020.09.004_bib47","first-page":"215","article-title":"Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol","volume":"9","author":"Naksuk","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jmii.2020.09.004_bib48","first-page":"948","article-title":"Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society","volume":"36","author":"Sapp","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jmii.2020.09.004_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mmcr.2014.03.001","article-title":"Voriconazole associated torsades de pointes in two adult patients with haematological malignancies","volume":"4","author":"Brown","year":"2014","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.jmii.2020.09.004_bib50","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1086\/423275","article-title":"Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect","volume":"39","author":"Alkan","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2020.09.004_bib51","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00228-017-2284-5","article-title":"Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors","volume":"73","author":"Gueta","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jmii.2020.09.004_bib52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","article-title":"Lopinavir\/ritonavir: a review of its use in the management of HIV infection","volume":"63","author":"Cvetkovic","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jmii.2020.09.004_bib53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200746080-00005","article-title":"General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs","volume":"46","author":"Ohno","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.jmii.2020.09.004_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2125.2003.01996.x","article-title":"No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers","volume":"56","author":"Purkins","year":"2003","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220302383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220302383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:26:08Z","timestamp":1761657968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118220302383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1684118220302383"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2020.09.004","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 associated with pulmonary aspergillosis: A literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}